Some myeloma updates by Manni Mohyuddin

Manni Mohyuddin shared on X:

“Thanks again to Medscape for the opportunity to write about some myeloma updates at ASCO24.

I focus on the return of belantamab, and the use of quads in newly diagnosed myeloma.

ASCO 2024: Treating Myeloma Just Got More Complicated.”

Source: Manni Mohyuddin/X

Dr. Manni Mohyuddin is an Assistant Professor at the Huntsman Cancer Institute, University of Utah, specializing in oncology. He is mainly interested in myeloma, supportive care, end-of-life management, and implementing cost-effective, evidence-based treatment strategies.